RecruitingNCT06568081
Digitally supported SloMo therapy for worries about harm in psychosis
About this title
Read the official source — NCT06568081Interventional studyAges 18+United KingdomSchizophrenia
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- LondonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 16, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 150
- Sponsor
- King's College London
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Locations
- United Kingdom
- Age range
- Over 18 Years
- Official registry ID
- NCT06568081
- Official title
Show the full official title
SloMo2: A Process Evaluation, Effectiveness, and Cost-effectiveness Study of a Digitally Supported Therapy for Psychosis in Routine Care
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is King's College London, a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Clozapine versus usual second-line treatment after a first schizophrenia treatment fails
A clinical trial to investigate how effective a stimulant medication is compared to a non-stimulant medication in patients who have been diagnosed with attention deficit hyperactivity disorder (ADHD) and also have a history of either psychosis or Bipolarity